London Stock Exchange welcomes 4basebio UK Societas to AIM

London Stock Exchange welcomes 4basebio UK Societas (“4basebio”, “4bb” or the “Company”) to AIM today. The Cambridge-based Company’s Ordinary Shares were admitted to trading at 8.00am on Wednesday 17th February 2021.  

The Company’s TIDM is 4BB.LON and at the Admission price of 118p, has a market capitalisation of £14.53m. No new equity has been raised.  

On 8 December 2020, the Company was spun-out of 4basebio AG (Heidelberg), which is listed on the Frankfurt Main Market, with that company now re-focusing as an investment and holding company.  

4bb is a life sciences company focused on exploiting its intellectual property in the field of gene therapies and DNA vaccines. Using its proprietary technology, 4bb is developing and supplying next generation therapeutic DNA, as well as non-viral nanoparticles for use in gene therapy delivery.

The Company’s focus is: 

•    developing a highly efficient and scalable manufacturing process for its proprietary synthetic hpDNATM with a view to manufacturing and selling large quantities of pharmaceutical grade DNA;
•    developing gene therapy delivery systems centred on non-viral nanoparticles; and
•    identifying a number of indications, where the combination of the company’s DNA and non-viral delivery system technology can be combined to progress potential gene therapies through pre-clinical development.

The immediate objectives of 4bb are to validate and scale its DNA synthesis process and advance its collaborations to facilitate the functional validation of its DNA based products and gene delivery solutions.

The Company is well-funded to achieve its development objectives, with approximate cash resources of £14.4million upon AIM admission.

Dr Heikki Lanckriet, Company CEO, commented: “We are delighted to be admitted to AIM today. As a Cambridge, UK based company with significant ambitions, we believe AIM is the ideal market to support our future growth.”

“We would like to thank London Stock Exchange for its warm welcome, and extend our thanks also to our staff, advisors and shareholders who have supported our ongoing development. We look forward to their continued support as we commence the next phase of our growth strategy.”

Quick facts

Market: AIM
Instrument market cap (£m)
Listing/Admission to trading
17 Feb 2021
Looking for new and recent issues?

More recent

London Stock Exchange welcomes Ukraine’s $1.25bn international sovereign bond to the Main Market

London Stock Exchange today welcomes Ukraine issuing its USD1.25bn 6.876% notes due May 2029 to London Stock Exchange’s Main Market. This is an inaugural listing of Ukraine’s sovereign Eurobonds on London Stock Exchange.
The new 8-year offering, which marked the first funding exercise of the Sovereign in international debt capital markets in 2021, received bids in excess of

Learn more
London Stock Exchange welcomes Glantus Holdings PLC to AIM

London Stock Exchange today welcomes Glantus to AIM under the ticker “GLAN”, after it raised gross proceeds of £10m for the Company and a further £4m for shareholders. The Placing Price was 102 pence per share resulting in a market capitalisation of £37m at Admission.

Glantus is a global provider of Accounts Payable (“AP”) automation and analytics solutions. It utilises a technology t

Learn more
London Stock Exchange welcomes Insig AI Plc to AIM

London Stock Exchange welcomes Insig AI Plc (ticker: INSG), a leading data science and machine learning company serving the asset management industry, to AIM today.

Insig AI joins AIM via a reverse takeover of its listed holding company Catena Group plc (“Catena”).  The new enlarged group is led by Executive Chairman, Matthew Farnum-Schneider, and Chief Executive Officer Ste

Learn more
London Stock Exchange welcomes Darktrace to the Premium Segment of the Main Market

Darktrace plc, the UK-based, leading autonomous cyber security AI company, has today reached a major milestone in its trajectory of rapid growth as it is admitted to the Premium Listing Segment of the Official List. It is trading on the Main Market of London Stock Exchange, having raised gross proceeds of £165m via a global share offer.  At the placing price of 250p per share, the company

Learn more